Apolipoprotein B is a new target of the GDNF/RET and ET-3/EDNRB signalling pathways

Neurogastroenterology and Motility

Volumn 24, Issue 10, 2012, Pages e497-e508

  Evangelisti, C ^a   Bianco, F ^a   Pradella, L M ^a   Puliti, A ^b,c   Goldoni, A ^a   Sbrana, I ^d   Rossi, M ^d   Vargiolu, M ^a   Seri, M ^a   Romeo, G ^a   Stanghellini, V ^a   De Giorgio, R ^a   Bonora, E ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c G GASLINI INSTITUTE   (Italy)

^d UNIVERSITY OF PISA   (Italy)

Author keywords

Apolipoprotein B; Enteric nervous system; Hirschsprung's disease; Neuro2a cell line

Indexed keywords

APOLIPOPROTEIN B; ENDOTHELIN 3; ENDOTHELIN B RECEPTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN P53; PROTEIN RET;

ANIMAL CELL; APOB GENE; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; GENE; GENE TARGETING; HIRSCHSPRUNG DISEASE; INTESTINE INNERVATION; MOUSE; NERVE CELL DIFFERENTIATION; NEURAL CREST CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84866277128     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2012.01998.x     Document Type: Article

References (35)

1. Gershon MD. Developmental determinants of the independence and complexity of the enteric nervous system. Trends Neurosci 2010; 33: 446-56.
2. Panza E, Knowles CH, Graziano C et al. Genetics of human enteric neuropathies. Prog Neurobiol 2012; 96: 176-89.
3. Amiel J, Lyonnet S. Hirschsprung disease, associated syndromes, and genetics: a review. J Med Genet 2001; 38: 729-39.
4. Arighi E, Borrello MG, Sariola H. RET tyrosine kinase signaling in development and cancer. Cytokine Growth Factor Rev 2005; 16: 441-67.
5. Emison ES, McCallion AS, Kashuk CS et al. A common sex-dependent mutation in a RET enhancer underlies Hirschsprung disease risk. Nature 2005; 434: 857-63.
6. Tahira T, Ishizaka Y, Itoh F, Sugimura T, Nagao M. Characterization of ret proto-oncogene mRNAs encoding two isoforms of the protein product in a human neuroblastoma cell line. Oncogene 1990; 5: 97-102.
7. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990; 348: 730-2.
8. Carrasquillo MM, McCallion AS, Puffenberger EG, Kashuk CS, Nouri N, Chakravarti A. Genome-wide association study and mouse model identify interaction between RET and EDNRB pathways in Hirschsprung disease. Nat Genet 2002; 32: 237-44.
9. McCallion AS, Stames E, Conlon RA, Chakravarti A. Phenotype variation in two-locus mouse models of Hirschsprung disease: tissue-specific interaction between Ret and Ednrb. Proc Natl Acad Sci U S A 2003; 100: 1826-31.
10. Barlow A, de Graaff E, Pachnis V. Enteric nervous system progenitors are coordinately controlled by the G protein-coupled receptor EDNRB and the receptor tyrosine kinase RET. Neuron 2003; 40: 905-16.
11. Kruger GM, Mosher JT, Tsai YH et al. Temporally distinct requirements for endothelin receptor B in the generation and migration of gut neural crest stem cells. Neuron 2003; 40: 917-29.
12. Spanier B, Stürzenbaum SR, Holden-Dye LM, Baumeister R. Caenorhabditis elegans neprilysin NEP-1: an effector of locomotion and pharyngeal pumping. J Mol Biol 2005; 352: 429-37.
13. Rutledge AC, Su Q, Adeli K. Apolipoprotein B100 biogenesis: a complex array of intracellular mechanisms regulating folding, stability, and lipoprotein assembly. Biochem Cell Biol 2010; 88: 251-67.
14. Linton MF, Farese RV Jr, Young SG. Familial hypobetalipoproteinemia. J Lipid Res 1993; 34: 521-41.
15. Soria LF, Ludwig EH, Clarke HRG, Vega GL, Grundy SM, McCarthy BJ. Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc Natl Acad Sci U S A 1989; 86: 587-91.
16. Huang LS, Voyiaziakis E, Markenson DF, Sokol KA, Hayek T, Breslow JL. apo B gene knockout in mice results in embryonic lethality in homozygotes and neural tube defects, male infertility, and reduced HDL cholesterol ester and apo A-I transport rates in heterozygotes. J Clin Invest 1995; 96: 2152-61.
17. Lin CH, Hsieh M, Fan SS. The promotion of neurite formation in Neuro2A cells by mouse Mob2 protein. FEBS Lett 2011; 585: 523-30.
18. Sanchez-Ferras O, Coutaud B, Djavanbakht SamaniT, Tremblay I, Souchkova O, Pilon N. Caudal-related homeobox (Cdx) protein-dependent integration of canonical Wnt signaling on paired-box 3 (Pax3) neural crest enhancer. J Biol Chem 2012; 287: 16623-35.
19. Yin L, Puliti A, Bonora E et al. C620R mutation of the murine ret proto-oncogene: loss of function effect in homozygotes and possible gain of function effect in heterozygotes. Int J Cancer 2007; 121: 292-300.
20. Mograbi B, Bocciardi R, Bourget I et al. Glial cell line-derived neurotrophic factor-stimulated phosphatidylinositol 3-kinase and Akt activities exert opposing effects on the ERK pathway: importance for the rescue of neuroectodermic cells. J Biol Chem 2001; 276: 45307-19.
21. Bunone G, Borrello MG, Picetti R et al. Induction of RET proto-oncogene expression in neuroblastoma cells precedes neuronal differentiation and is not mediated by protein synthesis. Exp Cell Res 1995; 217: 92-9.
22. De GiorgioR, Volta U, Stanghellini V et al. Neurogenic chronic intestinal pseudo-obstruction: antineuronal antibody-mediated activation of autophagy via Fas. Gastroenterology 2008; 135: 601-9.
23. Liu MT, Kuan YH, Wang J, Hen R, Gershon MD. 5-HT4 receptor-mediated neuroprotection and neurogenesis in the enteric nervous system of adult mice. J Neurosci 2009; 29: 9683-99.
24. Heanue TA, Pachnis V. Expression profiling the developing mammalian enteric nervous system identifies marker and candidate Hirschsprung disease genes. Proc Natl Acad Sci U S A 2006; 103: 6919-24.
25. Lu BC, Cebrian C, Chi X et al. Etv4 and Etv5 are required downstream of GDNF and Ret for kidney branching morphogenesis. Nat Genet 2009; 41: 1295-302.
26. Bonora E, Evangelisti C, Puliti A et al. Apolipoprotein B is a new target of the RET/GDNF signalling pathway -ESHG, 2011; A-863 (Abstract).
27. Cromwell WC, Barringer TA. Low-density lipoprotein and apolipoprotein B: clinical use in patients with coronary heart disease. Curr Cardiol Rep 2009; 11: 468-75.
28. Fujihara M, Bartels E, Nielsen LB, Handa JT. A human apoB100 transgenic mouse expresses human apoB100 in the RPE and develops features of early AMD. Exp Eye Res 2009; 88: 1115-23.
29. Feng Y, Wen J, Chang CC. p38 Mitogen-activated protein kinase and hematologic malignancies. Arch Pathol Lab Med 2009; 133: 850-6.
30. Brown L, Benchimol S. The involvement of MAPK signaling pathways in determining the cellular response to p53 activation: cell cycle arrest or apoptosis. J Biol Chem 2006; 281: 3832-40.
31. Hilliard S, Aboudehen K, Yao X, El-Dahr SS. Tight regulation of p53 activity by Mdm2 is required for ureteric bud growth and branching. Dev Biol 2011; 353: 354-66.
32. Okano HJ, Darnell RB. A hierarchy of Hu RNA binding proteins in developing and adult neurons. J Neurosci 1997; 17: 3024-37.
33. Wakamatsu Y, Weston JA. Sequential expression and role of Hu RNA-binding proteins during neurogenesis. Development 1997; 124: 3449-60.
34. De GiorgioR, Bovara M, Barbara G et al. Anti-HuD-induced neuronal apoptosis underlying paraneoplastic gut dysmotility. Gastroenterology 2003; 125: 70-9.
35. Veiga-Fernandes H, Coles MC, Foster KE et al. Tyrosine kinase receptor RET is a key regulator of Peyer's patch organogenesis. Nature 2007; 446: 547-51.